Oxidants in Acute and Chronic Lung Disease
Mannam P, Srivastava A, Sugunaraj JP, Lee PJ, Sauler M. Oxidants in Acute and Chronic Lung Disease. Journal Of Blood & Lymph 2014, 4: 1000128. PMID: 25705575, PMCID: PMC4335304, DOI: 10.4172/2165-7831.1000128.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsChronic obstructive pulmonary diseaseAcute lung injuryLung diseaseChronic lung diseaseObstructive pulmonary diseaseReactive oxygen speciesAnti-oxidant strategiesLung injuryPulmonary diseaseLung pathologyOxidant responsesConsistent benefitHomeostatic functionsBeneficial effectsAdverse effectsOxidant generationDiseaseBeneficial resultsOxygen speciesAcuteInjuryTherapyPathologyNovel areaImportant roleEndothelial PINK1 Mediates the Protective Effects of NLRP3 Deficiency during Lethal Oxidant Injury
Zhang Y, Sauler M, Shinn AS, Gong H, Haslip M, Shan P, Mannam P, Lee PJ. Endothelial PINK1 Mediates the Protective Effects of NLRP3 Deficiency during Lethal Oxidant Injury. The Journal Of Immunology 2014, 192: 5296-5304. PMID: 24778451, PMCID: PMC4047670, DOI: 10.4049/jimmunol.1400653.Peer-Reviewed Original ResearchConceptsAcute respiratory failurePTEN-induced putative kinase 1Respiratory failureWild-type miceNLRP3 deficiencyAutophagy/mitophagySpecific therapyProtective effectProtein NLRP3Oxidant injuryLung endotheliumHigh mortalityHyperoxiaGenetic deletionHigher basalIntermediate susceptibilityMiceOxidant generationPutative kinase 1PINK1 expressionProteasome activationNovel roleDouble knockoutEndotheliumKinase 1